CSR spending likely to be made mandatory

Chemical Weekly: The government is reportedly planning to tighten the Corporate Social Responsibility (CSR) provisions in the company law, virtually making it mandatory for companies to make their CSR spend, failing which they would be penalised.
Provisions to this effect – approved by the Union Cabinet – would come as part of the amendments to the company law that the Government is expected to move in Parliament in the coming days.
Under the proposed amendments, any unspent amount in a financial year has to be transferred to a CSR account, to be spent within the next three financial years. If after three years any amount is unutilised it has to be transferred to a Central Government-created fund specified in Schedule VII.
The proposed changes in CSR provisions would mean that India Inc. would lose the hitherto available leeway of not spending on CSR, but merely disclosing such a fact in the annual report that amounts were unspent due to specific reasons. Now, if the proposed amendments to the company law go through, the CSR non-compliance would invite penalties.
Looking for chemical products? Let suppliers reach out to you!
2026-06-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
72 Hours at API China: Where China’s API Export Industry Is Heading Next
-
ECHEMI WPO and Pharmaceutical Division Showcase Dual Strengths at the 94th API China, Tackling Pharmaceutical Export Challenges with Precision
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
Recommend Reading
-
2025 Cyclohexanone Market Review and 2026 Outlook in China
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Chemical Properties and Uses of Tetraetil
-
Wanhua Chemical Secures Key Patent for High-Purity Lactide Catalyst Streamlines PLA Production Process
-
Caviar Sales Surge in India as Imports Face 50 Percent Price Hike and Tight Wildlife Controls